Third-party clinical testing refers to clinical testing or pathological diagnosis and other services provided by an independent third-party institution with legal personality, independent of medical institutions.These organizations often include third-party medical testing organizations (also known as Independent Clinical Laboratory or ICL). They can provide a variety of clinical testing and pathological diagnostic services, including but not limited to hematology, immunology, biochemistry, microbiology, genomics and pathology.The emergence of these institutions can effectively improve the efficiency and quality of medical diagnosis, while also reducing medical costs and reducing medical burden.

The global Third Party Clinical Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The driving forces for the development of third-party clinical testing mainly include the following aspects:

Social development and the improvement of people's health awareness: With the development of society and the improvement of people's living standards, people's demand for medical services continues to increase, and their requirements for health and safety are also constantly increasing. This makes medical testing and diagnosis more and more important, thus promoting the development of third-party clinical testing.

Continuous advancement of technology and equipment: With the continuous advancement of medical technology and equipment, the accuracy and reliability of clinical testing have been greatly improved. This also enables third-party clinical testing institutions to better provide high-quality and efficient testing services to medical institutions.

Support from policies and regulations: In order to improve the quality and efficiency of medical services, governments and relevant institutions in various countries are actively promoting the development of third-party clinical testing. The support of these policies and regulations provides favorable conditions for the development of third-party clinical testing.

Needs of hospitals and doctors: Hospitals and doctors also need the support of third-party clinical testing agencies. Due to limited medical resources, hospitals and doctors often need to obtain more professional testing services through third-party clinical testing institutions to better provide treatment services to patients.

Increasing market competition: Competition in the third-party clinical testing market is also increasing. More and more companies are joining this field. In order to gain more market share, they need to continuously improve their technology and service levels, thus promoting the development of third-party clinical testing.

This report aims to provide a comprehensive presentation of the global market for Third Party Clinical Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Third Party Clinical Testing.

Report Scope

The Third Party Clinical Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Third Party Clinical Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Third Party Clinical Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Third Party Clinical Testing Market Report

Report Metric	Details
Report Name	Third Party Clinical Testing Market
Segment by Type	Biochemical Tests Immunity Tests Routine Blood Tests Others
Segment by Application	Personal Enterprise
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Labcorp, IQVIA, PAREXEL International Corporation, ICON Plc, Charles River Laboratories, Syneos Health, PPD (Pharmaceutical Product Development), Medpace, WuXi AppTec, Kingmed, Dian Diagnostics, Adicon Clinical Laboratories, Kindstar, DaAn Gene, Berry Genomics, Frontage Holdings, Centre Testing International, Shanghai Labway Clinical Laboratory
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Third Party Clinical Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Third Party Clinical Testing Market report?

Ans: The main players in the Third Party Clinical Testing Market are Labcorp, IQVIA, PAREXEL International Corporation, ICON Plc, Charles River Laboratories, Syneos Health, PPD (Pharmaceutical Product Development), Medpace, WuXi AppTec, Kingmed, Dian Diagnostics, Adicon Clinical Laboratories, Kindstar, DaAn Gene, Berry Genomics, Frontage Holdings, Centre Testing International, Shanghai Labway Clinical Laboratory

What are the Application segmentation covered in the Third Party Clinical Testing Market report?

Ans: The Applications covered in the Third Party Clinical Testing Market report are Personal, Enterprise

What are the Type segmentation covered in the Third Party Clinical Testing Market report?

Ans: The Types covered in the Third Party Clinical Testing Market report are Biochemical Tests, Immunity Tests, Routine Blood Tests, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Third Party Clinical Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Biochemical Tests

1.2.3 Immunity Tests

1.2.4 Routine Blood Tests

1.2.5 Others

1.3 Market by Application

1.3.1 Global Third Party Clinical Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Personal

1.3.3 Enterprise

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Third Party Clinical Testing Market Perspective (2019-2030)

2.2 Third Party Clinical Testing Growth Trends by Region

2.2.1 Global Third Party Clinical Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Third Party Clinical Testing Historic Market Size by Region (2019-2024)

2.2.3 Third Party Clinical Testing Forecasted Market Size by Region (2025-2030)

2.3 Third Party Clinical Testing Market Dynamics

2.3.1 Third Party Clinical Testing Industry Trends

2.3.2 Third Party Clinical Testing Market Drivers

2.3.3 Third Party Clinical Testing Market Challenges

2.3.4 Third Party Clinical Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Third Party Clinical Testing Players by Revenue

3.1.1 Global Top Third Party Clinical Testing Players by Revenue (2019-2024)

3.1.2 Global Third Party Clinical Testing Revenue Market Share by Players (2019-2024)

3.2 Global Third Party Clinical Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Third Party Clinical Testing Revenue

3.4 Global Third Party Clinical Testing Market Concentration Ratio

3.4.1 Global Third Party Clinical Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Third Party Clinical Testing Revenue in 2023

3.5 Third Party Clinical Testing Key Players Head office and Area Served

3.6 Key Players Third Party Clinical Testing Product Solution and Service

3.7 Date of Enter into Third Party Clinical Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Third Party Clinical Testing Breakdown Data by Type

4.1 Global Third Party Clinical Testing Historic Market Size by Type (2019-2024)

4.2 Global Third Party Clinical Testing Forecasted Market Size by Type (2025-2030)

5 Third Party Clinical Testing Breakdown Data by Application

5.1 Global Third Party Clinical Testing Historic Market Size by Application (2019-2024)

5.2 Global Third Party Clinical Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Third Party Clinical Testing Market Size (2019-2030)

6.2 North America Third Party Clinical Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Third Party Clinical Testing Market Size by Country (2019-2024)

6.4 North America Third Party Clinical Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Third Party Clinical Testing Market Size (2019-2030)

7.2 Europe Third Party Clinical Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Third Party Clinical Testing Market Size by Country (2019-2024)

7.4 Europe Third Party Clinical Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Third Party Clinical Testing Market Size (2019-2030)

8.2 Asia-Pacific Third Party Clinical Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Third Party Clinical Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Third Party Clinical Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Third Party Clinical Testing Market Size (2019-2030)

9.2 Latin America Third Party Clinical Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Third Party Clinical Testing Market Size by Country (2019-2024)

9.4 Latin America Third Party Clinical Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Third Party Clinical Testing Market Size (2019-2030)

10.2 Middle East & Africa Third Party Clinical Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Third Party Clinical Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Third Party Clinical Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Labcorp

11.1.1 Labcorp Company Detail

11.1.2 Labcorp Business Overview

11.1.3 Labcorp Third Party Clinical Testing Introduction

11.1.4 Labcorp Revenue in Third Party Clinical Testing Business (2019-2024)

11.1.5 Labcorp Recent Development

11.2 IQVIA

11.2.1 IQVIA Company Detail

11.2.2 IQVIA Business Overview

11.2.3 IQVIA Third Party Clinical Testing Introduction

11.2.4 IQVIA Revenue in Third Party Clinical Testing Business (2019-2024)

11.2.5 IQVIA Recent Development

11.3 PAREXEL International Corporation

11.3.1 PAREXEL International Corporation Company Detail

11.3.2 PAREXEL International Corporation Business Overview

11.3.3 PAREXEL International Corporation Third Party Clinical Testing Introduction

11.3.4 PAREXEL International Corporation Revenue in Third Party Clinical Testing Business (2019-2024)

11.3.5 PAREXEL International Corporation Recent Development

11.4 ICON Plc

11.4.1 ICON Plc Company Detail

11.4.2 ICON Plc Business Overview

11.4.3 ICON Plc Third Party Clinical Testing Introduction

11.4.4 ICON Plc Revenue in Third Party Clinical Testing Business (2019-2024)

11.4.5 ICON Plc Recent Development

11.5 Charles River Laboratories

11.5.1 Charles River Laboratories Company Detail

11.5.2 Charles River Laboratories Business Overview

11.5.3 Charles River Laboratories Third Party Clinical Testing Introduction

11.5.4 Charles River Laboratories Revenue in Third Party Clinical Testing Business (2019-2024)

11.5.5 Charles River Laboratories Recent Development

11.6 Syneos Health

11.6.1 Syneos Health Company Detail

11.6.2 Syneos Health Business Overview

11.6.3 Syneos Health Third Party Clinical Testing Introduction

11.6.4 Syneos Health Revenue in Third Party Clinical Testing Business (2019-2024)

11.6.5 Syneos Health Recent Development

11.7 PPD (Pharmaceutical Product Development)

11.7.1 PPD (Pharmaceutical Product Development) Company Detail

11.7.2 PPD (Pharmaceutical Product Development) Business Overview

11.7.3 PPD (Pharmaceutical Product Development) Third Party Clinical Testing Introduction

11.7.4 PPD (Pharmaceutical Product Development) Revenue in Third Party Clinical Testing Business (2019-2024)

11.7.5 PPD (Pharmaceutical Product Development) Recent Development

11.8 Medpace

11.8.1 Medpace Company Detail

11.8.2 Medpace Business Overview

11.8.3 Medpace Third Party Clinical Testing Introduction

11.8.4 Medpace Revenue in Third Party Clinical Testing Business (2019-2024)

11.8.5 Medpace Recent Development

11.9 WuXi AppTec

11.9.1 WuXi AppTec Company Detail

11.9.2 WuXi AppTec Business Overview

11.9.3 WuXi AppTec Third Party Clinical Testing Introduction

11.9.4 WuXi AppTec Revenue in Third Party Clinical Testing Business (2019-2024)

11.9.5 WuXi AppTec Recent Development

11.10 Kingmed

11.10.1 Kingmed Company Detail

11.10.2 Kingmed Business Overview

11.10.3 Kingmed Third Party Clinical Testing Introduction

11.10.4 Kingmed Revenue in Third Party Clinical Testing Business (2019-2024)

11.10.5 Kingmed Recent Development

11.11 Dian Diagnostics

11.11.1 Dian Diagnostics Company Detail

11.11.2 Dian Diagnostics Business Overview

11.11.3 Dian Diagnostics Third Party Clinical Testing Introduction

11.11.4 Dian Diagnostics Revenue in Third Party Clinical Testing Business (2019-2024)

11.11.5 Dian Diagnostics Recent Development

11.12 Adicon Clinical Laboratories

11.12.1 Adicon Clinical Laboratories Company Detail

11.12.2 Adicon Clinical Laboratories Business Overview

11.12.3 Adicon Clinical Laboratories Third Party Clinical Testing Introduction

11.12.4 Adicon Clinical Laboratories Revenue in Third Party Clinical Testing Business (2019-2024)

11.12.5 Adicon Clinical Laboratories Recent Development

11.13 Kindstar

11.13.1 Kindstar Company Detail

11.13.2 Kindstar Business Overview

11.13.3 Kindstar Third Party Clinical Testing Introduction

11.13.4 Kindstar Revenue in Third Party Clinical Testing Business (2019-2024)

11.13.5 Kindstar Recent Development

11.14 DaAn Gene

11.14.1 DaAn Gene Company Detail

11.14.2 DaAn Gene Business Overview

11.14.3 DaAn Gene Third Party Clinical Testing Introduction

11.14.4 DaAn Gene Revenue in Third Party Clinical Testing Business (2019-2024)

11.14.5 DaAn Gene Recent Development

11.15 Berry Genomics

11.15.1 Berry Genomics Company Detail

11.15.2 Berry Genomics Business Overview

11.15.3 Berry Genomics Third Party Clinical Testing Introduction

11.15.4 Berry Genomics Revenue in Third Party Clinical Testing Business (2019-2024)

11.15.5 Berry Genomics Recent Development

11.16 Frontage Holdings

11.16.1 Frontage Holdings Company Detail

11.16.2 Frontage Holdings Business Overview

11.16.3 Frontage Holdings Third Party Clinical Testing Introduction

11.16.4 Frontage Holdings Revenue in Third Party Clinical Testing Business (2019-2024)

11.16.5 Frontage Holdings Recent Development

11.17 Centre Testing International

11.17.1 Centre Testing International Company Detail

11.17.2 Centre Testing International Business Overview

11.17.3 Centre Testing International Third Party Clinical Testing Introduction

11.17.4 Centre Testing International Revenue in Third Party Clinical Testing Business (2019-2024)

11.17.5 Centre Testing International Recent Development

11.18 Shanghai Labway Clinical Laboratory

11.18.1 Shanghai Labway Clinical Laboratory Company Detail

11.18.2 Shanghai Labway Clinical Laboratory Business Overview

11.18.3 Shanghai Labway Clinical Laboratory Third Party Clinical Testing Introduction

11.18.4 Shanghai Labway Clinical Laboratory Revenue in Third Party Clinical Testing Business (2019-2024)

11.18.5 Shanghai Labway Clinical Laboratory Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

LabCorp

IQVIA

PAREXEL International Corporation

ICON

Charles River Laboratories

Adicon Clinical Laboratories

Centre Testing International

Shanghai Labway Clinical Laboratory

PPD (Pharmaceutical Product Development)

List of Tables

Table 1. Global Third Party Clinical Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Biochemical Tests

Table 3. Key Players of Immunity Tests

Table 4. Key Players of Routine Blood Tests

Table 5. Key Players of Others

Table 6. Global Third Party Clinical Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Third Party Clinical Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Third Party Clinical Testing Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Third Party Clinical Testing Market Share by Region (2019-2024)

Table 10. Global Third Party Clinical Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Third Party Clinical Testing Market Share by Region (2025-2030)

Table 12. Third Party Clinical Testing Market Trends

Table 13. Third Party Clinical Testing Market Drivers

Table 14. Third Party Clinical Testing Market Challenges

Table 15. Third Party Clinical Testing Market Restraints

Table 16. Global Third Party Clinical Testing Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Third Party Clinical Testing Market Share by Players (2019-2024)

Table 18. Global Top Third Party Clinical Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third Party Clinical Testing as of 2023)

Table 19. Ranking of Global Top Third Party Clinical Testing Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Third Party Clinical Testing Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Third Party Clinical Testing Product Solution and Service

Table 23. Date of Enter into Third Party Clinical Testing Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Third Party Clinical Testing Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Third Party Clinical Testing Revenue Market Share by Type (2019-2024)

Table 27. Global Third Party Clinical Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Third Party Clinical Testing Revenue Market Share by Type (2025-2030)

Table 29. Global Third Party Clinical Testing Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Third Party Clinical Testing Revenue Market Share by Application (2019-2024)

Table 31. Global Third Party Clinical Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Third Party Clinical Testing Revenue Market Share by Application (2025-2030)

Table 33. North America Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Third Party Clinical Testing Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Third Party Clinical Testing Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Third Party Clinical Testing Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Third Party Clinical Testing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Third Party Clinical Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Third Party Clinical Testing Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Third Party Clinical Testing Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Third Party Clinical Testing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Third Party Clinical Testing Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Third Party Clinical Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Third Party Clinical Testing Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Third Party Clinical Testing Market Size by Country (2025-2030) & (US$ Million)

Table 48. Labcorp Company Detail

Table 49. Labcorp Business Overview

Table 50. Labcorp Third Party Clinical Testing Product

Table 51. Labcorp Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 52. Labcorp Recent Development

Table 53. IQVIA Company Detail

Table 54. IQVIA Business Overview

Table 55. IQVIA Third Party Clinical Testing Product

Table 56. IQVIA Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 57. IQVIA Recent Development

Table 58. PAREXEL International Corporation Company Detail

Table 59. PAREXEL International Corporation Business Overview

Table 60. PAREXEL International Corporation Third Party Clinical Testing Product

Table 61. PAREXEL International Corporation Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 62. PAREXEL International Corporation Recent Development

Table 63. ICON Plc Company Detail

Table 64. ICON Plc Business Overview

Table 65. ICON Plc Third Party Clinical Testing Product

Table 66. ICON Plc Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 67. ICON Plc Recent Development

Table 68. Charles River Laboratories Company Detail

Table 69. Charles River Laboratories Business Overview

Table 70. Charles River Laboratories Third Party Clinical Testing Product

Table 71. Charles River Laboratories Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 72. Charles River Laboratories Recent Development

Table 73. Syneos Health Company Detail

Table 74. Syneos Health Business Overview

Table 75. Syneos Health Third Party Clinical Testing Product

Table 76. Syneos Health Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 77. Syneos Health Recent Development

Table 78. PPD (Pharmaceutical Product Development) Company Detail

Table 79. PPD (Pharmaceutical Product Development) Business Overview

Table 80. PPD (Pharmaceutical Product Development) Third Party Clinical Testing Product

Table 81. PPD (Pharmaceutical Product Development) Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 82. PPD (Pharmaceutical Product Development) Recent Development

Table 83. Medpace Company Detail

Table 84. Medpace Business Overview

Table 85. Medpace Third Party Clinical Testing Product

Table 86. Medpace Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 87. Medpace Recent Development

Table 88. WuXi AppTec Company Detail

Table 89. WuXi AppTec Business Overview

Table 90. WuXi AppTec Third Party Clinical Testing Product

Table 91. WuXi AppTec Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 92. WuXi AppTec Recent Development

Table 93. Kingmed Company Detail

Table 94. Kingmed Business Overview

Table 95. Kingmed Third Party Clinical Testing Product

Table 96. Kingmed Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 97. Kingmed Recent Development

Table 98. Dian Diagnostics Company Detail

Table 99. Dian Diagnostics Business Overview

Table 100. Dian Diagnostics Third Party Clinical Testing Product

Table 101. Dian Diagnostics Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 102. Dian Diagnostics Recent Development

Table 103. Adicon Clinical Laboratories Company Detail

Table 104. Adicon Clinical Laboratories Business Overview

Table 105. Adicon Clinical Laboratories Third Party Clinical Testing Product

Table 106. Adicon Clinical Laboratories Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 107. Adicon Clinical Laboratories Recent Development

Table 108. Kindstar Company Detail

Table 109. Kindstar Business Overview

Table 110. Kindstar Third Party Clinical Testing Product

Table 111. Kindstar Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 112. Kindstar Recent Development

Table 113. DaAn Gene Company Detail

Table 114. DaAn Gene Business Overview

Table 115. DaAn Gene Third Party Clinical Testing Product

Table 116. DaAn Gene Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 117. DaAn Gene Recent Development

Table 118. Berry Genomics Company Detail

Table 119. Berry Genomics Business Overview

Table 120. Berry Genomics Third Party Clinical Testing Product

Table 121. Berry Genomics Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 122. Berry Genomics Recent Development

Table 123. Frontage Holdings Company Detail

Table 124. Frontage Holdings Business Overview

Table 125. Frontage Holdings Third Party Clinical Testing Product

Table 126. Frontage Holdings Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 127. Frontage Holdings Recent Development

Table 128. Centre Testing International Company Detail

Table 129. Centre Testing International Business Overview

Table 130. Centre Testing International Third Party Clinical Testing Product

Table 131. Centre Testing International Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 132. Centre Testing International Recent Development

Table 133. Shanghai Labway Clinical Laboratory Company Detail

Table 134. Shanghai Labway Clinical Laboratory Business Overview

Table 135. Shanghai Labway Clinical Laboratory Third Party Clinical Testing Product

Table 136. Shanghai Labway Clinical Laboratory Revenue in Third Party Clinical Testing Business (2019-2024) & (US$ Million)

Table 137. Shanghai Labway Clinical Laboratory Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Third Party Clinical Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Third Party Clinical Testing Market Share by Type: 2023 VS 2030

Figure 3. Biochemical Tests Features

Figure 4. Immunity Tests Features

Figure 5. Routine Blood Tests Features

Figure 6. Others Features

Figure 7. Global Third Party Clinical Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Third Party Clinical Testing Market Share by Application: 2023 VS 2030

Figure 9. Personal Case Studies

Figure 10. Enterprise Case Studies

Figure 11. Third Party Clinical Testing Report Years Considered

Figure 12. Global Third Party Clinical Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Third Party Clinical Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Third Party Clinical Testing Market Share by Region: 2023 VS 2030

Figure 15. Global Third Party Clinical Testing Market Share by Players in 2023

Figure 16. Global Top Third Party Clinical Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Third Party Clinical Testing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Third Party Clinical Testing Revenue in 2023

Figure 18. North America Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Third Party Clinical Testing Market Share by Country (2019-2030)

Figure 20. United States Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Third Party Clinical Testing Market Share by Country (2019-2030)

Figure 24. Germany Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Third Party Clinical Testing Market Share by Region (2019-2030)

Figure 32. China Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Third Party Clinical Testing Market Share by Country (2019-2030)

Figure 40. Mexico Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Third Party Clinical Testing Market Share by Country (2019-2030)

Figure 44. Turkey Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Third Party Clinical Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Labcorp Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 47. IQVIA Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 48. PAREXEL International Corporation Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 49. ICON Plc Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 50. Charles River Laboratories Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 51. Syneos Health Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 52. PPD (Pharmaceutical Product Development) Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 53. Medpace Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 54. WuXi AppTec Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 55. Kingmed Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 56. Dian Diagnostics Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 57. Adicon Clinical Laboratories Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 58. Kindstar Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 59. DaAn Gene Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 60. Berry Genomics Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 61. Frontage Holdings Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 62. Centre Testing International Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 63. Shanghai Labway Clinical Laboratory Revenue Growth Rate in Third Party Clinical Testing Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Epilepsy Treatment Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-17F16370

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Cervical Cell Sample Storage Solution Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21C18032

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

Global Third Party Clinical Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3H15989

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

Global Reproductive Genetics Medical Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3V15600

Wed Aug 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions